~," A vascular permeability factor (VPF) derived from serum-free conditioned medium of cultured human malignant gliomas (HG-VPF) has been described previously. The rapid kinetics of HG-VPF activity in an in vivo assay of vascular permeability suggests a direct action upon the vascular endothelial cell. To determine whether HG-VPF was capable of inducing a physiologically significant alteration in isolated endothelial cells, cytosolic calcium [Ca++]i was measured in vitro in these cells before and after their exposure to media containing this substance. This was accomplished by preloading cultured endothelial cells with a fluorescent intracellular Ca *+ probe fura-2/AM.
V
ASOGENIC cerebral edema commonly accompanies malignant primary and metastatic brain tumors. It can also occur in certain benign tumors, such as meningioma. As the mass effect resulting from edema is often as culpable for neurological deterioration as the tumor mass, much interest has been focused on this troublesome clinical problem. Early investigations distinguished vasogenic cerebral edema on a morphological basis, from edema associated with cerebral ischemia, hydrocephalus, and water intoxication. 2'4'~5 Studies of tumor vascular ultrastructure revealed variations from the typical morphology of blood-Cytosolic calcium changes in endothelial ceils brain barrier microvessels. "-''7-~9 The finding of abundant micropinocytotic vesicles, capillary fenestrations, discontinuous tight junctions, and widened intercellular junctions made these tumor vessels appear inherently permeable to macromolecular substances. This premise is supported by radioisotope tracer studies which show the water component of vasogenic brain edema to be derived primarily from the tumor site, and not from the surrounding peritumoral cerebral vasculature. However, many cerebral neoplasms display similar morphological alterations in their microvasculature in the absence of cerebral edema. Furthermore, many features of tumor vessels are common to normal microvessels in extraneural tissues. Morphological changes alone do not, therefore, fully explain the occurrence of vascular extravasation.
Prior experience with a vascular permeability factor (VPF) derived from cultured human malignant glioma cells (HG-VPF) 3' 5 prompted an inquiry as to whether this substance acted directly upon isolated endothelial cells. Considerable evidence exists linking well-characterized mediators of vascular permeability (histamine, bradykinin) with changes in endothelial cytosolic calcium, reduction of F-actin content, cytoskeletal alterations, and subsequent microvascular leakage. 6"' 62~' 22"~' 4" 25,z8,3o The effect of HG-VPF upon this apparently relevant physiological cascade was investigated. To accomplish this, the fluorescent calcium ion probe fura-2/AM was used to determine whether HG-VPF could induce alterations in cytosolic calcium homeostasis in isolated endothelial cells in vitro. The endothelial cell cultures used were obtained from organs (placenta, lung, adrenal, brain) of several species (human, bovine, rat), and were representative of both macrovascular and microvascular, as well as arterial and venous systems.
Materials and Methods

Human Glioma Cell Culture
Cells derived from a cloned human malignant glioma (U251) were used as the source of HG-VPF activity. They were cultured at 37~ in 95% air and 5% CO2, at 100% humidity in Dulbecco's modified Eagle's medium (DMEM) supplemented with L-glutamine (4 mM), penicillin (100 U/ml), streptomycin (100 ug/ml), and 10% fetal calf serum (FCS). Newly confluent cultures grown in Falcon tissue culture flasks (175 sq cm growth area) were washed three times with Hanks' balanced salt solution (HBSS) without calcium, magnesium, or phenol red and incubated with 25 ml of serum-free DMEM for 24 hours; next, they were again rinsed and placed in 30 ml of fresh serum-free DMEM. The cells were then allowed to incubate for 5 to 7 days and the conditioned serum-free medium was harvested.
Flasks of confluent cells were subcultured, using standard trypsinization procedures, every 5 to 20 days as necessitated by biological growth patterns. Confluent flasks contained 6 x 107 to 8 x 107 cells with viability greater than 98% as determined by the trypan blue dyeexclusion method. Staining for glial fibrillary acidic protein (GFAP) confirmed the glial origin of the stock cultures. Stock cultures were periodically monitored for Mycoplasma infection.
Preparation (~f Human Glioma-Derived Protein
Conditioned medium was stored frozen at -20~ and later concentrated 20-to 40-fold in 3-to 6-liter batches, using wet-tubing dialysis* against 0.05 M ammonium bicarbonate, titrated to pH 7.4 with glacial acetic acid, followed by shell freezing in super-cooled acetone and lyophilization for 48 hours. Lowry protein determinations 2~ were performed and proved 95 % positive for lyophilized sample weight. The lyophilized product was reconstituted in Dulbecco's phosphatebuffered saline without calcium, magnesium, or phenol red, and filtered through a 0.45-~m membranet before assaying for HG-VPF activity. Removal of VPF activity, as determined by the Miles assay, was achieved by heparin affinity chromatography? This flow-through (non-VPF-containing) product served as a useful negative control for other brain tumor-derived substances present in the lyophilized product. However, limitations in the quantity of VPF activity available required the use of partially purified product (dialyzed/lyophilized, non-heparin-purified) as the VPF stimulus for the current studies. Previous determinations have shown HG-VPF to comprise less than 0.01% of this crude extract?
Miles Microvascular Permeability Assay
The Miles assay is a biological assay for the induction of capillary permeability in normal skin following the intradermal injection of test substances. A modification of the original assay, described previously for brain tumor-derived HG-VPF activity, 3,s was used in this study. After induction of anesthesia with diethyl ether, previously shaved 450-to 500-gm male Hartley-strain guinea pigs:~ were given an intracardiac injection of 1% Evans blue dye and 10 uCi (2.22 x 107 disintegrations per minute (dpm)) of ~25I-bovine serum albumin (125I-BSA, specific activity 2.0 uCi/ug)w in a total volume of 1.0 ml, using a No. 25 permeability caused a visible blue stain at the injection site due to extravasation of the Evans blue dye-albumin complex. After 30 minutes, the animals were exsanguihated and the injection sites were excised with a 5-mm circular leather-punch. This method produces skin tags of constant surface area and weight, which consistently encompassed the small areas of dye extravasation produced by the 50-#1 injection volumes. The VPF activity within these injection sites was quantified directly using a gamma counter and is expressed as dpm.
Endothelial Cell Isolation and Culture
Human umbilical vein endothelial cells were obtained by collagenase digestion of umbilical cords collected at Caesarean section, 9'3'4 or obtained directly from the American Type Culture Collection (ATCC).* Harvested cells were plated in flasks coated with 2% gelatin containing medium-199 supplemented with Lglutamine (2 mM), heparin (100 um/ml), thymidine (10 uM), 15% FCS, 10% conditioned medium (derived from normal glia, glial tumor, and a variety of endothelial cell cultures), and endothelial cell growth supplement (50 ug/ml). All cell cultures were maintained at 37~ in 95% air and 5% CO2 at 100% humidity. At confluence, cultures were suspended in trypsin-ethylenediaminetetra-acetic acid (EDTA, 0.05%) and passaged at a 1:4 split ratio. Stock cultures at passage 1 or 2 were routinely frozen in 5% dimethyl sulfoxide, 5% dextran-70, and 90% FCS by means of a programmable cell freezer;t they were then stored in vapor-phase nitrogen, and periodically thawed and replanted in medium-! 99 supplemented as above. Fura-2/AM studies were restricted to low-passage cultures that displayed morphological characteristics of vascular endothelium under phase-contrast microscopy. Furthermore, their endothelial identity was confirmed by Factor VIII immunofluorescent staining and uptake of acetylated lowdensity lipoprotein (LDL). 9' 13' 14' 36 Contamination by cells with morphological features and the growth characteristics of smooth-muscle cells was not observed.
Bovine pulmonary artery endothelial cells~ were obtained directly from ATCC at Passage 22. They had previously been characterized as having an intact glycocalyx and surface receptors, as well as having positive immunofluorescent staining for Factor VIII and angiotensin-converting enzyme. 26 ' 27 In addition, they displayed typical cobblestone monolayer morphology when examined by phase-contrast microscopy. These cells were cultured at 37~ in 95% air and 5% CO2 at 100% humidity in medium-199 containing Earle's salts and L-glutamine (4 mM), supplemented with heparin (100 ug/ml), thymidine (10 uM), sodium bicarbonate * Human umbilical vein endothelial cells obtained from the American Type Culture Collection, Rockville, Maryland.
t Programmable cell freezer manufactured by Cryo-Med, Inc., Mount Clemens, Michigan.
z~ Bovine pulmonary artery endothelial cells supplied by the American Type Culture Collection, Rockville, Maryland.
(4.35 gm/liter), penicillin (100 U/ml), and streptomycin (100 ug/ml). Cultures were grown on gelatin-coated flasks and subcultured at a split ratio of 1:2 upon reaching confluence.
Bovine adrenal medullary endothelial cells were obtained by collagenase digestion of adrenal glands obtained fresh from the abattoir. Isolation of pure endothelial cell lines was achieved by gross dissection of digested glands, passage of digested adrenal medullary tissue through a series of nylon mesh filters, and by differential plating. Their endothelial identity was confirmed by immunofluorescent staining for Factor VIII and uptake of acetylated LDL (DiI-Ac-LDL), and the absence of cells staining for smooth-muscle actin. Phase-contrast microscopy revealed a characteristic propensity of the cells to form capillary-like structures when grown in monolayers. Cultures were maintained at 37~ in 95% air and 5% CO2 at 100% humidity in Eagle's modified essential medium supplemented with L-glutamine (2 mM), endothelial cell growth supplement (20 ug/ml), penicillin (100 U/ml), streptomycin (100 ug/ml), and 10% FCS. This cell line was routinely grown on uncoated flasks. Passage was carried out using trypsin-EDTA (0.05%) and subculturing at a 1:4 split ratio.
Cerebral microvessel endothelial cells were obtained by harvesting Fisher 344 rat brains. Gentle ether anesthesia was followed by rapid decapitation and aseptic removal of the cerebral tissue. The brains were then washed in 10:1 volumes HBSS and minced in media containing both antibiotics and antimycotics until a uniform slurry of tissue particles less than 1.0 mm was achieved. The slurry was then digested with protease (0.5% in 300 mM sucrose)w for 30 minutes at 37~ followed by neutralization of the enzymatic activity with 10% BSA. The tissue was homogenized with six to eight strokes using a loosely fitting glass pestle at slow speed. The final purification involved differential plating and clonal isolation of cells which showed typical morphological features on phase-contrast microscopy, and fluorescent staining for Factor VIII and uptake of DiI-Ac-LDL. The cells of interest showed no evidence of staining for GFAP or smooth-muscle actin. Cell cultures were maintained at 37~ in 95% air and 5% CO2 at 100% humidity. The culture medium used consisted of medium-199 with L-glutamine (2.5 mM), Earle's salts, and a combined sodium bicarbonate/ HEPES buffer system (2.0 gm/liter and 10 raM). This medium was further supplemented with endothelial cell growth supplement (25 ug/ml), heparin (100 ug/ml), thymidine (10 uM), 12.5% FCS, 15% U251 glioblastoma clone conditioned medium (48 to 96 hours old), 5% to 10% rat brain glial and endothelial cell conditioned medium, penicillin (100 U/ml), streptomycin (100 ug/ml), and amphotericin B (2.5 ug/ml for the first week only).
w Dispase type II sucrose obtained from Boehringer Mannheim, West Germany.
Fura-2/AM Loading
Confluent cultures were washed with Ca++/Mg++-free HBSS and incubated at 37~ for 5 to 10 minutes in the same buffer containing 25 mM EDTA. This method minimized alteration of surface receptors and membrane proteins that might otherwise be damaged by standard trypsinization techniques. Retracted cells were readily suspended by gentle agitation, diluted in an equal volume of HBSS, pelleted, washed, and resuspended in HBSS. Endothelial cells (approximately 107 cells/ml medium) were routinely loaded by incubation with 5.0 uM fura-2/AM for 30 minutes. A loading incubation temperature of 15 ~ to 20~ was used to minimize nonhomogeneous concentration of the probe by sequestration into perinuclear acidic organelles. 23 The residual extracellular fura-2/AM was then diluted 1:10 by adding the appropriate quantity of medium, and the cells were again allowed to equilibrate at 15 ~ to 20~ for 30 minutes. The cells were gently washed three times by pelleting (8000 rpm x 5 minutes) and then resuspending them in 20 to 30 ml of culture medium not containing fura-2/AM. The final pellet was suspended in 1 ml of medium and contained 2 x 107 cells/ ml. This suspension was stored on ice until used. Preliminary experiments showed negligible fura-2 leakage (< 5% after storage for up to 4 hours) and experiments were routinely completed within that interval.
Fluorescence Measurements
Fluorescence measurements were performed using a spectrofluorometer equipped with a temperature-controlled magnetically stirred cuvette holder and interfaced with a spectroscopy laboratory coordinator and a recorder or printer. II All assays were conducted at 37~ Excitation and emission wavelengths were 340 and 510 nm, respectively; the gain was adjusted to provide a fluorescence of approximately 50% of full scale. The data collected were real-time recordings after establishing a baseline steady state for at least 2 minutes. Assays were conducted in disposable plastic cuvettes loaded with 2 x 10 6 cells (final concentration approximately 1 x 10 6 cells/ml) suspended in 2 ml of modified KrebsRinger solution containing 35 mM NaC1, 5 Mm KCI, 1 mM MgC12, 2 mM CaCI2, 10 mM glucose, and l0 mM HEPES and adjusted to a pH of 7.4 _+ 0.1 with NaOH. Calibration of fura-2 fluorescence was performed as previously described. 24 Maximum and minimum fluorescence values were recorded at 10 .3 M Ca ++ and 10 .0 M Ca ++ by first lysing cells in Triton X-100 or digitonin, respectively, followed by chelation of free Ca ++ on addition of 4 mM ethyleneglycol-bis (~-aminoethylether)-N,N'-tetra-acetic acid (EGTA) and II Fluorolog spectrophotometer and Model DMIB spectroscopy laboratory coordinator manufactured by SPEX Industries, Inc., Edison, New Jersey; R-100A recorder manufactured by Perkin-Elmer Corp., Norwalk, Connecticut: HIPLOT printer. Model DMP-40, manufactured by Bausch and Lomb, Austin, Texas. 
Fmaximum -Eobserved
Figures 1 through 6 represent computer-generated tracings of the original hard-copy real-time data. This was accomplished after conversion of the y-axis peak emission values, using the formula shown above to arrive at absolute intracellular calcium values [Ca++]i expressed in nanomolar concentrations (nM).
Results
The basal level of [Ca++]i in unstimulated endothelial cells was found to be between 50 and 100 ~M, irrespective of the tissue source of the cells. Human gliomaderived VPF induced significant cytosolic calcium ion transients in all endothelial cell lines examined (Fig. 1 ) ; however, it did not elicit a calcium response in two non-endothelial cell lines, U251 glioma and fibroblasts (data not shown). Endothelial responses were typically rapid or slightly delayed in onset (15 to 45 seconds), and varied in magnitude depending upon the cell type being studied. The largest responses were observed in human endothelial cells. Peak HG-VPF-induced [Ca++]~ elevations were attained within 60 seconds, exhibited a dose-response phenomenon, and were followed by a sustained elevation above baseline for 5 to 10 minutes thereafter (Fig. 2) . In contrast, exposure of endothelial cells to the flow-through product of human glioma-derived conditioned medium after binding of all HG-VPF activity to a heparin-Sepharose affinity As elevated extracellular potassium chloride (120 mM [K+]e) did not induce cytosolic calcium transients, it is unlikely that HG-VPF acts via voltage-gated calcium channels. Similarly, verapamil (10 -6 M) failed to inhibit HG-VPF-induced calcium changes. This suggests that HG-VPF increases cytosolic Ca ++ by a mechanism other than calcium entry via verapamil-sensitive calcium channels (Fig. 3) . Furthermore, addition of 2 mM Li +, Co ++, Mn + § or La § inhibited the HG-VPFo induced calcium transient in vitro, as did the absence * Column obtained from Pharmacia, Inc., Piscataway, New Jersey.
of extracellular Ca ++ after chelation with EGTA. This indicates that HG-VPF-induced changes largely depend upon the influx of extracellular calcium through membranous calcium channels independent of the voltagesensitive variety (Fig. 4) . Finally, incubation of endothelial cells for 2 hours with 10 t~M dexamethasone before exposure of HG-VPF-containing medium resuited in inhibition of the HG-VPF-induced cytosolic changes (Fig. 5 ). This inhibitory effect was not observed in similarly treated cells exposed to cyclic adenosine monophosphate, suggesting that the steroid-induced inhibition was specific for HG-VPF-induced calcium influx.
Another polycationic substance (protamine) induced changes in intracellular calcium (Fig. 6 left) at concentrations as low as 10 ug/ml. Induction of calcium transients by protamine was rapid in onset, peaked within 30 seconds, and sustained a level above baseline for a number of minutes thereafter. The presence of competing extracellular divalent cations (2 mM Co ++ and Mn ++) reduced peak [Ca++] i, but more completely affected the post-maximum levels, resulting in a rapid downslope and normalization of intracellular calcium (Fig. 6 right) . These findings indicated that combined mobilization of intracellular calcium stores (rapid upslope and peak levels) as well as influx from the extracellular compartment (peak and sustained post-maximum levels) are involved in the response to HG-VPF and protamine. Moreover, the effects of HG-VPF and protamine were inhibited in the presence of heparin, a polyanionic glycoprotein (data not shown).
Discussion
Cytosolic free Ca ++ plays important roles in many physiological cellular processes including reduction of F-actin content, cytoskeletal alterations, and subsequent microvascular extravasation. 6,'~176 Studies of cytosolic calcium changes have recently been facilitated by novel calcium ion chelators (quin-2/AM, indo-1/AM, and fura-2/AM) possessing molecular structures similar to EGTA. ~1' 33 They are available as sodium salts and acetoxy-methyl esters. The latter form is useful for intracellular Ca ++ determinations. These agents differ from EGTA in that they possess aromatic tings capable of electrostatic interactions with the functional groups that participate in the chelation of Ca ++ . This interaction during chelation changes the fluorescence and ultraviolet light-absorption properties of these molecules. The spectral changes allow these molecules to be used as sensitive probes for divalent cations.
Fura-2/AM is particularly useful in that it is highly specific for Ca ++ ions, readily distinguishing them from other divalent cations. Furthermore, it is sensitive to Ca ++ changes in the nanomolar range that are encountered within endothelial cells. Fura-2 produces a potent fluorescent emission (30 x Fquin-2) which allows its use in relatively low concentrations, thereby lowering any interference due to an inherent Ca ++ buffering capacity. Because of its lipophilicity, fura-2/AM is rapidly internalized by endothelial cells. Once internalized, deesterification of the acetoxy-methyl group (fura-2/AM-->fura-2) converts it to the free acid (lipophobic form), which has minimal capability to diffuse out of the cell. Residual extracellular fura-2/AM, removed by a series of cell washings, assures that observed fluorescence changes correspond solely to alterations in intracellular Ca ++.
Human glioma-derived VPF is an acid-stable, heat labile protein of 41-to 56-kD molecular weight) '5 Coincubating glial tumor cells with concentrations of dexamethasone compatible with those achieved in patients being treated for neoplastic brain edema inhibits expression of HG-VPF? Activity is also inhibited by pretreating test animals with dexamethasone, an effect which is partially reversed by exposing the test animals to inhibitors of protein synthesis before dexamethasone treatment? Inhibition of HG-VPF activity by dexamethasone in vitro and in vivo correlates well with the efficacy of this agent in treating neoplastic vasogenic cerebral edema. It is possible that HG-VPF may act upon the prostaglandin cascade via activation of phospholipase-A2, the rate-limiting enzyme in that pathway. This postulate is based upon evidence of inhibition of VPF activity by antagonists of cyclo-oxygenase (indomethacin) and by dexamethasone. 3' 5 The latter agent potently inhibits phospholipase-A2 indirectly by inducing synthesis of an intermediate referred to as "lipocortin," "macrocortin," or "endocortin. ''~'v'8 The effects of dexamethasone upon VPF activity have been shown to be inhibited by prior exposure to protein synthesis inhibitors, ~ thus suggesting a link to this steroid-inducible cascade, and therefore phospholipase-A2 (and prostaglandins). Other investigators have shown prostaglandins to be potent inducers of calcium transients in endothelial cells. 8 The observation that dexamethasone inhibition of HG-VPF occurs through a direct interaction with the endothelial cell provides new insight into the use of corticosteroids, which has hitherto been largely empirical in this setting.
Human glioma-derived VPF is a positively charged (cationic) protein which has an affinity for heparin, 3'5'29 a polyanionic substance coating up to 85% of the endothelial cell surface. Exposure of endothelial cell suspensions to heparin before administration of HG-VPF inhibits the induction of calcium transients by HG-VPF and protamine. The mechanism by which surface charge neutralization by polycationic molecules (HG-VPF and protamine) results in alterations in intracellular calcium is not known. In fact, the data available at this time do not eliminate the possibility of a specific HG-VPF cell-surface receptor interaction. A number of studies have demonstrated and discussed the induction of microvascular permeability by polycationic substances. Intracarotid infusion of protamine produces vascular extravasation of Evans blue dye into the rabbit brain. 3~ Similarly, poly-l-lysine, another positively charged molecule, produces protein leakage (nephrotic syndrome) after exposure of the renal vasculature in rats. 34 '35 It has been hypothesized that these cationic agents act by neutralizing the negatively charged (anionic) endothelial cell surface. Ultrastructural studies have shown a reorganization of renal epithelial podocyte processes in the poly-l-lysine-induced nephrotic syndrome. 3s However, there is no prior direct evidence to support and explain the physiological basis of these interactions. It was found that, like VPF, protamine produces significant cytosolic calcium transients in fura-2-1oaded endothelial cell suspensions. Furthermore, this action is attenuated by the presence of extracellular divalent cations capable of competing with calcium for transmembranous ion channels. Premixing protamine with heparin also inhibited the action of protamine upon the endothelial cells.
Further investigation of the subcellular mechanisms of HG-VPF activity is warranted. This will require increasingly pure preparations of this substance, as well as antibodies directed against its active site and putative receptor. Increased understanding of the mechanism of neoplastic cerebral edema may lead to improved treatments for this important accompaniment of intracranial tumors. Possibilities suggested by the results of experiments reported here include the use of specific calcium channel blocking agents or less specific cationic salts (lithium carbonate) to treat vasogenic cerebral edema associated with brain tumors. These substances may ultimately prove to be useful adjuncts, if not alternatives, to high-dose corticosteroid therapy.
